Evidence map›Paper›PMID 36219317›Full record

ArticleJournal of experimental orthopaedics2022

The Saturne cementless dual-mobility cup grants satisfactory long-term survival.

Thierry Gaillard, Sonia Ramos-Pascual, Mo Saffarini, Jean-Pierre Piton

Abstract read
In one paragraph

Article in Journal of experimental orthopaedics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Thierry GaillardPolyclinique du Beaujolais, 120 Anc. Rte de Beaujeu, 69400, Arnas, France.
Sonia Ramos-PascualReSurg SA, Rue Saint-Jean 22, 1260, Nyon, Switzerland. journals@resurg.com.ORCID http://orcid.org/0000-0002-0409-613X
Mo SaffariniReSurg SA, Rue Saint-Jean 22, 1260, Nyon, Switzerland.
Jean-Pierre PitonUNEOS - Hôpitaux Privés de Metz, 15 Rue de Sarre, 57070, Metz, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo report long-term survival and clinical outcomes of primary total hip arthroplasty (THA) using a Saturne cementless dual-mobility (DM) cup, and investigate whether patient demographics or surgical parameters affect clinical scores.

methodsA consecutive series of primary THAs implanted with Saturne cementless DM cups between 01/09/2009-31/12/ 2011 was retrospectively assessed. Patients were postoperatively evaluated using modified Harris hip score (mHHS) and forgotten joint score (FJS). Complications, reoperations, and revisions were noted. Regression analyses were performed to determine associations of postoperative mHHS with preoperative and intraoperative variables. Ten-year Kaplan-Meier survival was calculated.

resultsOf 308 patients (308 hips), 111 (36%) had died with their original cups in place, 29 (9%) were lost-to-follow-up, and 5 (2%) required cup revision, leaving a final cohort of 163 (53%) with their original cup in place at a follow-up of ≥ 10 years. Ten-year survival was 98% considering cup revision for any reason as endpoint; 99% considering cup revision for aseptic loosening as endpoint; 96% considering stem revision for any reason as endpoint; and 96% considering any revision as endpoint. The final cohort of 163 patients was assessed at 11 ± 1 years (range, 10-13), mHHS was 85 ± 16 (range, 31-100) and FJS was 84 ± 24 (range, 0-100). Multivariable regression analysis revealed that postoperative mHHS significantly worsened with age (β = -0.48, p = 0.007) and BMI (β = -0.70, p = 0.008), as well as for 22 mm head sizes (β = -6.98, p = 0.046).

conclusionsThe Saturne DM cup granted satisfactory survival and clinical outcomes at a minimum follow-up of 10 years, and resulted in no cases of intra- or extra-prosthetic dislocations.

Indexed as

Clinical scoresLong-term outcomesTotal hip arthroplasty

Identifiers

PMID36219317
PMCPMC9552733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.